NRIX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 7.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $293,700.72

Nurix Therapeutics Insider Trading History Chart

Nurix Therapeutics Share Price & Price History

^$14.44

▲ +0.36 (2.56%)

As of 04/18/2024 01:00 AM ET

Days: 30 | 90 | 365

The #1 Crypto for 2024

From InvestorPlace | Ad

5 Tiny Cryptos That Could Soar During 2024 Crypto Bull Run One of the first ever crypto millionaires who bought Bitcoin when it was trading for just $5 in 2011 is back with his next huge prediction. A newly approved government regulation is set to flood trillions of dollars into the crypto markets, leading to the FINAL crypto bull run. One of the "Kings of Crypto" has revealed five tiny cryptos that could soar over the course of 2024. Potentially resulting in gains as big as 10X, 50X, or even 100X over the next 12 months.

Get His #1 Coin For 2024 FREE By Clicking Here

Nurix Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
2/16/2024	Houte Hans Van	CFO	Sell	6,812	$10.02	$68,256.24	68,333
1/30/2024	Gwenn Hansen	Insider	Sell	2,334	$7.99	$18,648.66	36,402
1/30/2024	Houte Hans Van	CFO	Sell	1,671	$7.99	$13,351.29	75,145
12/19/2023	Houte Hans Van	CFO	Sell	10,906	$10.00	$109,060.00	75,471
10/31/2023	Christine Ring	Insider	Sell	1,232	$5.20	$6,406.40	15,263
10/31/2023	Houte Hans Van	CFO	Sell	1,080	$5.20	$5,616.00	86,377
7/31/2023	Christine Ring	General Counsel	Sell	1,420	$9.65	$13,703.00	12,544
7/31/2023	Gwenn Hansen	Insider	Sell	1,884	$9.65	$18,180.60	29,955
7/31/2023	Houte Hans Van	CFO	Sell	1,245	$9.65	$12,014.25	82,571
5/1/2023	Christine Ring	General Counsel	Sell	682	$9.88	$6,738.16	10,040
5/1/2023	Gwenn Hansen	Insider	Sell	1,136	$9.88	$11,223.68	26,632
5/1/2023	Houte Hans Van	CFO	Sell	721	$9.88	$7,123.48	78,930
5/1/2023	Stefani Wolff	COO	Sell	342	$9.88	$3,378.96	6,113
1/30/2023	Christine Ring	General Counsel	Sell	848	$11.78	$9,989.44	7,261
1/30/2023	Gwenn Hansen	Insider	Sell	1,412	$11.78	$16,633.36	23,009
1/30/2023	Houte Hans Van	CFO	Sell	924	$11.78	$10,884.72	76,765
1/30/2023	Stefani Wolff	COO	Sell	424	$11.78	$4,994.72	3,940
10/31/2022	Christine Ring	General Counsel	Sell	699	$12.88	$9,003.12	6,185
10/31/2022	Gwenn Hansen	Insider	Sell	1,165	$12.88	$15,005.20	21,214
10/31/2022	Houte Hans Van	CFO	Sell	739	$12.88	$9,518.32	74,803
10/31/2022	Stefani Wolff	COO	Sell	350	$12.88	$4,508.00	3,402
8/1/2022	Christine Ring	General Counsel	Sell	712	$15.67	$11,157.04	4,615
8/1/2022	Gwenn Hansen	Insider	Sell	1,186	$15.67	$18,584.62	19,172
8/1/2022	Houte Hans Van	CFO	Sell	752	$15.67	$11,783.84	72,656
8/1/2022	Stefani Wolff	COO	Sell	356	$15.67	$5,578.52	1,238
5/2/2022	Christine Ring	General Counsel	Sell	660	$11.75	$7,755.00	3,403
5/2/2022	Gwenn Hansen	Insider	Sell	1,098	$11.75	$12,901.50	17,151
5/2/2022	Houte Hans Van	CFO	Sell	697	$11.75	$8,189.75	2,189
5/2/2022	Stefani Wolff	COO	Sell	330	$11.75	$3,877.50	632
12/10/2021	Christine Ring	General Counsel	Sell	1,200	$29.04	$34,848.00
12/1/2021	Gwenn Hansen	Insider	Sell	400	$29.13	$11,652.00
11/1/2021	Gwenn Hansen	Insider	Sell	400	$33.24	$13,296.00
10/27/2021	Christine Ring	General Counsel	Sell	800	$35.25	$28,200.00
10/27/2021	Gwenn Hansen	Insider	Sell	400	$35.00	$14,000.00
10/11/2021	Christine Ring	General Counsel	Sell	1,200	$27.36	$32,832.00
10/1/2021	Gwenn Hansen	Insider	Sell	400	$29.92	$11,968.00
9/7/2021	Christine Ring	General Counsel	Sell	3,200	$35.25	$112,800.00
9/7/2021	Gwenn Hansen	Insider	Sell	1,600	$35.00	$56,000.00	15,797
8/10/2021	Christine Ring	General Counsel	Sell	1,200	$29.87	$35,844.00	2,005
8/10/2021	Pierre Beaurang	Insider	Sell	7,500	$29.86	$223,950.00
8/2/2021	Gwenn Hansen	Insider	Sell	400	$31.21	$12,484.00	14,204
7/20/2021	Christine Ring	General Counsel	Sell	1,200	$27.00	$32,400.00
7/12/2021	Pierre Beaurang	Insider	Sell	7,500	$23.92	$179,400.00	11,830
6/10/2021	Christine Ring	General Counsel	Sell	1,200	$29.40	$35,280.00	2,005
6/10/2021	Pierre Beaurang	Insider	Sell	7,500	$29.37	$220,275.00	11,830
6/1/2021	Gwenn Hansen	Insider	Sell	400	$27.74	$11,096.00	14,204
5/10/2021	Christine Ring	General Counsel	Sell	1,200	$27.00	$32,400.00	2,005

Bitcoin Rockets To Record High But Buy THIS Instead

From Paradigm Press | Ad

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

>>Click here to find out what it is.

SEC Filings (Institutional Ownership Changes) for Nurix Therapeutics (NASDAQ:NRIX)

Institutional Buying and Selling by Quarter

Nurix Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
4/18/2024	Wasatch Advisors LP	1,236,753	$18.18M	0.1%	-55.0%	2.516%
4/5/2024	Los Angeles Capital Management LLC	102,321	$1.50M	0.0%	-18.8%	0.208%
3/11/2024	Vanguard Group Inc.	2,598,097	$26.81M	0.0%	-4.3%	5.314%
3/5/2024	Wellington Management Group LLP	205,324	$2.12M	0.0%	+41.6%	0.420%
3/1/2024	Goldman Sachs Group Inc.	281,900	$2.91M	0.0%	-22.5%	0.577%
2/16/2024	Price T Rowe Associates Inc. MD	2,389,966	$24.67M	0.0%	+0.5%	4.928%
2/16/2024	GSA Capital Partners LLP	24,091	$0.25M	0.0%	-87.7%	0.050%
2/16/2024	Public Employees Retirement System of Ohio	49,018	$0.51M	0.0%	+35.6%	0.101%
2/15/2024	Virtus ETF Advisers LLC	10,356	$0.11M	0.1%	+14.9%	0.021%
2/15/2024	Legal & General Group Plc	6,896	$71K	0.0%	-78.4%	0.014%
2/15/2024	Barclays PLC	68,739	$0.71M	0.0%	+1.9%	0.142%
2/15/2024	Vanguard Group Inc.	2,598,097	$26.81M	0.0%	-4.3%	5.357%
2/15/2024	Voya Investment Management LLC	38,456	$0.40M	0.0%	+16.6%	0.079%
2/15/2024	Nuveen Asset Management LLC	533,865	$5.51M	0.0%	-19.5%	1.101%
2/15/2024	Oracle Alpha Inc.	17,434	$0.18M	0.2%	N/A	0.036%
2/15/2024	Price T Rowe Associates Inc. MD	2,389,966	$24.67M	0.0%	+0.5%	4.928%
2/15/2024	Brevan Howard Capital Management LP	11,068	$0.11M	0.0%	N/A	0.023%
2/14/2024	Royal Bank of Canada	14,923	$0.15M	0.0%	+84.1%	0.031%
2/14/2024	Pennant Investors LP	56,800	$0.59M	0.1%	N/A	0.117%
2/14/2024	Nebula Research & Development LLC	12,894	$0.13M	0.0%	N/A	0.027%
2/14/2024	Putnam Investments LLC	61,717	$0.64M	0.0%	N/A	0.127%
2/14/2024	Wasatch Advisors LP	2,749,745	$28.38M	0.2%	-22.9%	5.670%
2/14/2024	Balyasny Asset Management L.P.	22,581	$0.23M	0.0%	-14.1%	0.047%
2/13/2024	Northern Trust Corp	416,814	$4.30M	0.0%	-5.5%	0.859%
2/13/2024	Tower Research Capital LLC TRC	23,605	$0.24M	0.0%	+2,558.2%	0.049%
2/13/2024	Affinity Asset Advisors LLC	690,112	$7.12M	1.3%	+176.0%	1.423%
2/13/2024	Goldman Sachs Group Inc.	281,900	$2.91M	0.0%	-22.5%	0.581%
2/13/2024	California State Teachers Retirement System	7,835	$81K	0.0%	-82.4%	0.016%
2/12/2024	Hsbc Holdings PLC	67,323	$0.70M	0.0%	+40.1%	0.139%
2/9/2024	Quest Partners LLC	5,725	$59K	0.0%	N/A	0.012%
2/9/2024	Trexquant Investment LP	159,318	$1.64M	0.0%	+80.9%	0.328%
2/9/2024	UBS Group AG	76,402	$0.79M	0.0%	-55.6%	0.158%
2/9/2024	Norges Bank	258,400	$2.67M	0.0%	N/A	0.533%
2/8/2024	Massachusetts Financial Services Co. MA	142,146	$1.47M	0.0%	+248.2%	0.293%
2/7/2024	Principal Financial Group Inc.	14,135	$0.15M	0.0%	-9.0%	0.029%
2/7/2024	Dimensional Fund Advisors LP	1,000,044	$10.32M	0.0%	+4.4%	2.062%
2/7/2024	Jump Financial LLC	15,332	$0.16M	0.0%	N/A	0.032%
2/6/2024	Charles Schwab Investment Management Inc.	622,297	$6.42M	0.0%	+9.4%	1.283%
2/5/2024	AtonRa Partners	21,102	$0.22M	0.4%	-12.9%	0.044%
2/1/2024	New York State Common Retirement Fund	16,156	$0.17M	0.0%	+59.5%	0.033%
1/25/2024	International Assets Investment Management LLC	12,126	$1.18M	0.0%	N/A	0.025%
1/24/2024	Mirae Asset Global Investments Co. Ltd.	24,276	$0.25M	0.0%	-11.3%	0.050%
1/24/2024	International Assets Investment Management LLC	12,126	$1.18M	0.0%	N/A	0.025%
1/24/2024	China Universal Asset Management Co. Ltd.	5,611	$58K	0.0%	+351.0%	0.012%
1/19/2024	Denali Advisors LLC	57,500	$0.59M	0.2%	N/A	0.119%
1/17/2024	ARK Investment Management LLC	3,194,999	$32.97M	0.2%	+23.2%	6.588%
1/16/2024	Raymond James & Associates	101,006	$1.04M	0.0%	+3.1%	0.208%
1/12/2024	SG Americas Securities LLC	26,601	$0.28M	0.0%	+28.9%	0.055%
1/5/2024	Exchange Traded Concepts LLC	15,823	$0.16M	0.0%	+34.0%	0.033%
12/19/2023	Public Employees Retirement System of Ohio	36,138	$0.28M	0.0%	-58.0%	0.075%
12/18/2023	Vanguard Group Inc.	2,714,845	$21.34M	0.0%	+0.8%	5.598%
12/6/2023	Citigroup Inc.	42,200	$0.33M	0.0%	-10.1%	0.087%
12/1/2023	Wellington Management Group LLP	145,053	$1.14M	0.0%	+3.0%	0.299%
11/30/2023	American Century Companies Inc.	30,839	$0.24M	0.0%	+33.7%	0.064%
11/24/2023	Deutsche Bank AG	19,595	$0.15M	0.0%	+24.4%	0.040%
11/17/2023	Jacobs Levy Equity Management Inc.	247,080	$1.94M	0.0%	+426.9%	0.509%
11/16/2023	Public Employees Retirement System of Ohio	36,138	$0.28M	0.0%	-58.0%	0.075%
11/15/2023	GSA Capital Partners LLP	195,420	$1.54M	0.1%	+1,012.4%	0.403%
11/15/2023	Redmile Group LLC	2,848,827	$22.39M	1.1%	-0.3%	5.874%
11/15/2023	Kennedy Capital Management LLC	163,623	$1.29M	0.0%	+192.7%	0.337%
11/15/2023	Ameriprise Financial Inc.	60,318	$0.47M	0.0%	N/A	0.124%
11/15/2023	Affinity Asset Advisors LLC	250,000	$1.97M	0.6%	+150.0%	0.515%
11/14/2023	Lazard Asset Management LLC	5,674	$44K	0.0%	-34.5%	0.012%
11/14/2023	California State Teachers Retirement System	44,585	$0.35M	0.0%	-12.7%	0.092%
11/14/2023	Trexquant Investment LP	88,066	$0.69M	0.0%	+57.7%	0.182%
11/14/2023	Profund Advisors LLC	17,233	$0.14M	0.0%	-18.9%	0.036%
11/13/2023	Connor Clark & Lunn Investment Management Ltd.	183,923	$1.45M	0.0%	+40.9%	0.379%
11/13/2023	Northern Trust Corp	440,852	$3.47M	0.0%	+2.8%	0.909%
11/13/2023	Hsbc Holdings PLC	48,065	$0.38M	0.0%	+40.0%	0.099%
11/13/2023	FMR LLC	320,907	$2.52M	0.0%	-23.0%	0.662%
11/13/2023	Rafferty Asset Management LLC	98,839	$0.78M	0.0%	-13.7%	0.204%
11/9/2023	Rhumbline Advisers	75,049	$0.59M	0.0%	+2.7%	0.155%
11/9/2023	Deutsche Bank AG	19,595	$0.15M	0.0%	+24.4%	0.040%
11/9/2023	Citigroup Inc.	42,200	$0.33M	0.0%	-10.1%	0.087%
11/9/2023	UBS Group AG	172,002	$1.35M	0.0%	+113.3%	0.355%
11/8/2023	Charles Schwab Investment Management Inc.	568,576	$4.47M	0.0%	+48.1%	1.172%
11/8/2023	Massachusetts Financial Services Co. MA	40,826	$0.32M	0.0%	+96.2%	0.084%
11/8/2023	Swiss National Bank	84,800	$0.67M	0.0%	-3.5%	0.175%
11/6/2023	Los Angeles Capital Management LLC	125,839	$0.99M	0.0%	+15.6%	0.259%
11/2/2023	Principal Financial Group Inc.	15,531	$0.12M	0.0%	+14.8%	0.032%
10/31/2023	Panagora Asset Management Inc.	18,171	$0.14M	0.0%	-79.6%	0.037%
10/25/2023	AtonRa Partners	24,227	$0.19M	0.4%	-19.6%	0.050%
10/24/2023	Bank of New York Mellon Corp	170,286	$1.34M	0.0%	+2.9%	0.351%
10/24/2023	Raymond James & Associates	97,988	$0.77M	0.0%	+6.0%	0.202%
10/18/2023	ARK Investment Management LLC	2,593,047	$20.38M	0.2%	+14.7%	5.346%
10/13/2023	SG Americas Securities LLC	20,639	$0.16M	0.0%	N/A	0.043%
8/21/2023	Affinity Asset Advisors LLC	100,000	$1M	0.3%	-33.3%	0.207%
8/21/2023	California State Teachers Retirement System	51,061	$0.51M	0.0%	+5.7%	0.106%
8/16/2023	Nuveen Asset Management LLC	667,417	$6.67M	0.0%	-0.4%	1.385%
8/15/2023	Alliancebernstein L.P.	121,460	$1.21M	0.0%	+234.6%	0.252%
8/15/2023	Wells Fargo & Company MN	40,013	$0.40M	0.0%	+19.7%	0.083%
8/15/2023	Public Employees Retirement System of Ohio	85,986	$0.86M	0.0%	-6.0%	0.178%
8/15/2023	Goldman Sachs Group Inc.	322,648	$3.22M	0.0%	-40.3%	0.669%
8/15/2023	Lazard Asset Management LLC	8,660	$86K	0.0%	+200.8%	0.018%
8/15/2023	Royal Bank of Canada	5,804	$58K	0.0%	+112.9%	0.012%
8/15/2023	Suvretta Capital Management LLC	280,760	$2.81M	0.1%	N/A	0.582%
8/15/2023	Kennedy Capital Management LLC	55,904	$0.56M	0.0%	N/A	0.116%
8/14/2023	Tudor Investment Corp Et Al	12,991	$0.13M	0.0%	-41.2%	0.027%
8/14/2023	Tower Research Capital LLC TRC	2,624	$26K	0.0%	-76.4%	0.005%
8/14/2023	State of Wisconsin Investment Board	27,997	$0.28M	0.0%	-4.4%	0.058%

Data available starting January 2016

Nurix Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule and cell therapies for the treatment of cancer, inflammatory conditions, and other diseases. The company develops NX-2127, an orally bioavailable Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; and NX-1607, an orally bioavailable Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor for immuno-oncology indications. It is also developing NX-0479/GS-6791, a IRAK4 degrader for the treatment of rheumatoid arthritis and other inflammatory diseases. The company has a strategic collaboration agreement with Gilead Sciences, Inc., Sanofi S.A., and Seagen Inc. co-development and co-commercialization for multiple drug candidates. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. Nurix Therapeutics, Inc. was incorporated in 2009 and is headquartered in San Francisco, California.

Today's Range

Now: $14.44

$13.64

$14.60

50 Day Range

MA: $13.13

$8.72

$17.48

52 Week Range

Now: $14.44

$4.22

$18.12

Volume

972,955 shs

Average Volume

1,271,047 shs

Market Capitalization

$709.73 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.06

Who are the company insiders with the largest holdings of Nurix Therapeutics?: Nurix Therapeutics' top insider investors include:
Houte Hans Van (CFO)
Gwenn Hansen (Insider)
Christine Ring (Insider)
Christine Ring (General Counsel)
Stefani Wolff (COO)
Learn More about top insider investors at Nurix Therapeutics.
Who are the major institutional investors of Nurix Therapeutics?: Nurix Therapeutics' top institutional investors include:
Wasatch Advisors LP — 2.52%
Los Angeles Capital Management LLC — 0.21%
Learn More about top institutional investors of Nurix Therapeutics stock.
Which institutional investors are selling Nurix Therapeutics stock?: During the last quarter, NRIX stock was sold by these institutional investors:
Wasatch Advisors LP
Los Angeles Capital Management LLC
Within the last year, company insiders that have sold Nurix Therapeutics company stock include:
Houte Hans Van (CFO)
Gwenn Hansen (Insider)
Christine Ring (Insider)
Christine Ring (General Counsel)
Stefani Wolff (COO)
Learn More investors selling Nurix Therapeutics stock.